Olivier Rigaud
Chief Executive Officer
Replay available
Corbion NV (OTC: CSNVY) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Chief Financial Officer
Analyst, Barclays Bank
Analyst, ABN AMRO
Analyst, DeGroof Petercam
Analyst, Sanlanscott Kempin
Analyst, ING
Good morning, everyone, and welcome to Corbian's first half 2025 results conference call. This morning, we published our half-year 2025 results, press release, and presentations. These can be found on our website, www.CorbianRelationsFinancialPublications. Before we begin, please note that today's discussion will include forward-looking statements based on current expectations and assumptions. These statements involve risks and uncertainties that may cause actual results to differ materially from those expressed. Factors beyond our control, including market condition, economic changes, and regulatory actions, can impact outcomes. Corbian does not undertake any obligation to update statements made in this call or contained in today's press release and presentation. For more details on our assumptions and estimates, please refer to our annual reports. With me on the call today are Olivier Rigaud, Chief Executive Officer, and Peter Casius, Chief Financial Officers. Now, I would like to hand the call over to Olivier. Thank you, Alex, and good morning. And thank you all for joining us today. corbin's half year 2025 earning calls let's start with some key highlights from our latest results i'm pleased to report for the half year we achieved an increase in sales driven by robust demand and delivering on our strategic initiatives we achieved an organic sales of 645 million euros for the half year results corresponding to a plus 2.9 organic sales growth rate As anticipated at Q1 2025 reporting back in April, phasing of sales into Q1 resulted in a lower sales level in Q2. Our volume mix growth came in at plus 3.3% for the half year, with a Q2 growth at minus 1.3%, again, reflecting the phasing effects. In terms of EBITDA development, we've seen significant improvements. Our ad...